Article thumbnail

Role of Heparanase on Hepatic Uptake of Intestinal Derived Lipoprotein and Fatty Streak Formation in Mice

By David Planer, Shulamit Metzger, Eyal Zcharia, Isaiah D. Wexler, Israel Vlodavsky and Tova Chajek-Shaul
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2001). 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptordeficient mice.
  2. (1999). Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intimamedia thickness in healthy, middle-aged men.
  3. (1979). Atherogenesis: a postprandial phenomenon.
  4. (2007). Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing.
  5. (1997). Cell-surface heparan sulfate proteoglycans: dynamic molecules mediating ligand catabolism.
  6. Chylomicronemia elicits atherosclerosis in mice—brief report.
  7. (2010). Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects.
  8. (2000). Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice.
  9. (2008). Delayed metabolism of postprandial triglyceride-rich lipoproteins in subjects with echolucent carotid plaques.
  10. (1990). Effect of chronic heparin administration on serum lipolytic activity and some aspects of lipid metabolism.
  11. (1990). Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis.
  12. (2007). Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons.
  13. (2007). Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.
  14. (1994). Hepatic clearance of chylomicron remnants in mice lacking apoprotein E.
  15. (1999). Human heparanase. Purification, characterization, cloning, and expression.
  16. (2005). In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.
  17. (1995). Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans.
  18. (2006). Lipoprotein lipase bound to apolipoprotein B lipoproteins accelerates clearance of postprandial lipoproteins in humans.
  19. (1994). Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride-rich lipoproteins.
  20. (2007). Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members.
  21. (2005). Loss of heparan N-sulfotransferase in diabetic liver: role of angiotensin II.
  22. (1999). Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis.
  23. (2008). Molecular processes that handle — and mishandle — dietary lipids.
  24. (2000). Perlecan heparan sulfate proteoglycan: a novel receptor that mediates a distinct pathway for ligand catabolism.
  25. (2008). PI-88: a novel inhibitor of angiogenesis.
  26. (2000). Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease.
  27. Recent insights into factors affecting remnant lipoprotein uptake.
  28. (2001). Reduced body fat and increased hepatic lipid synthesis in mice bearing interleukin-6-secreting tumor.
  29. (1992). Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.
  30. (1996). Role of the low density lipoprotein (LDL) receptor pathway in the metabolism of chylomicron remnants. A quantitative study in knockout mice lacking the LDL receptor, apolipoprotein E, or both.
  31. (2008). Spontaneous atherosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet.
  32. (2007). Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.
  33. (2009). Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice.
  34. (2004). Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior.
  35. (1994). Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.